Clinical Research Directory

Inclusion Criteria: * Willing and able to provide informed consent and participate in the required study visit * Subjects determined to have signs and symptoms of evaporative Dry Eye disease due to MGD, defined by the following: * OSDI score \>13 and * NITBUT \<= 10sec Exclusion Criteria: * No use of warm compresses, intense pulsed light therapy or other lid warming treatment in the past 6 Months * Patients with greater 75% meibomian gland loss * Presence of ocular pathology or systemic conditions other than previously diagnosed moderate or severe chronic dry eye and/or Sjogren's syndrome, that in the investigator's judgment may affect the testing for, or diagnosis of, dry eye if present * Use of prescribed ocular topical medication (e.g., anti-hypertensive, steroid, Cyclosporin A, antibiotic) within the last 24 hours * Artificial tear usage within 2 hours prior to study testing * Other invasive ocular diagnostic testing within 2 hours prior to study testing * Eye makeup present on the eye lid within 10 minutes prior to study testing